Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
co.don chondrosphere versus microfracture for knee cartilage defects
2009-016466-82Phase 3Completed
- Sponsor
- CO.DON GmbH
- Start
- Nov 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Condrosphere in cartilage defect of knee and Knee Osteochondral Defect (OCD) (2 arms), sponsored by CO.DON GmbH. Primary endpoint: Change in overall KOOS at 24 months. Started Nov 2009; status: completed.
02
Drugs
Condrosphere
03
Conditions
cartilage defect of kneeKnee Osteochondral Defect (OCD)
Beyond the preview
Go deeper on 2009-016466-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016466-82.